Ann Dever

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Left Ventricular

Pulmonary Artery

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Sanjay Rajagopalan, Mirela A Dobre, Jean-Eudes Dazard, Armando Vergara-Martel, Kim Connelly, Michael E Farkouh, Juan Gaztanaga, Heather Conger, Ann Dever, Laleh Razavi-Nematollahi, Anas Fares, Gabriel Tensol Rodrigues Pereira, Jonnelle M Edwards, Mark J Cameron, Cheryl Cameron, Sadeer G Al-Kindi, Robert D Brook, Bertram Pitt, Matthew R Weir
Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial. Circulation (2024)
Sanjay Rajagopalan, Mirela A Dobre, Jean-Eudes Dazard, Armando Vergara-Martel, Kim Connelly, Michael E Farkouh, Juan Gaztanaga, Heather Conger, Ann Dever, Laleh Razavi-Nematollahi, Anas Fares, Gabriel Tensol Rodrigues Pereira, Jonnelle M Edwards, Mark J Cameron, Cheryl Cameron, Sadeer G Al-Kindi, Robert D Brook, Bertram Pitt, Matthew R Weir
Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial. Circulation 150 (9) (2024)
Sanjay Rajagopalan, Mirela A Dobre, Jean-Eudes Dazard, Armando Vergara-Martel, Kim Connelly, Michael E Farkouh, Juan Gaztanaga, Heather Conger, Ann Dever, Laleh Razavi-Nematollahi, Anas Fares, Gabriel Tensol Rodrigues Pereira, Jonnelle M Edwards, Mark J Cameron, Cheryl Cameron, Sadeer G Al-Kindi, Robert D Brook, Bertram Pitt, Matthew R Weir
Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial. Circulation 150 (9) (2024)